Prof. Yanik received his BS and MS at MIT in Engineering and Physics, and PhD at Stanford in Applied Physics. He completed postdoctoral work in Stanford Bioengineering and Neurosurgery Departments with Steve Quake and Theo Palmer. He is currently tenured Associate Professor at MIT, and founder an...
Prof. Yanik received his BS and MS at MIT in Engineering and Physics, and PhD at Stanford in Applied Physics. He completed postdoctoral work in Stanford Bioengineering and Neurosurgery Departments with Steve Quake and Theo Palmer. He is currently tenured Associate Professor at MIT, and founder and chairman of Entera Pharmaceuticals specializing in high-throughput technologies for drug discovery. His work on high-throughput neurobiology and neuronal regeneration is recognized by NIH Director's Pioneer Award (youngest recipient), NIH Director's New Innovator Award, NIH Transformative Research Award, Packard Award in Engineering and Science, Alfred Sloan Award in Neuroscience, NIH Eureka (Exceptional Unconventional Research Enabling Knowledge Acceleration) Award, Shillman Career Award, NSF Career Award, Silicon Valley Innovator's Challenge Award, Technology Review Magazine's "World's Top 35 Innovators under age 35", Junior Chamber International's "Outstanding Young Person", and Technology Research News Magazine's "Top ten advances of the year". His team's studies have been highlighted in ABC, The Economist, Scientific American, Nature, New Scientist, Biophotonics International, Popular Mechanics, Nature Physics, The Scientist, Genome Technology, and others.